news
Grifols has received a $21 million grant from The Michael…
23 January 2025 | By Drug Target Review
Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying early biomarkers for Parkinson's disease (PD).